Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding
Others
Ratios

NewAmsterdam Pharma (NAMSW) Shares Outstanding (Weighted Average) (2022 - 2023)

Historic Shares Outstanding (Weighted Average) for NewAmsterdam Pharma (NAMSW) over the last 2 years, with Q2 2023 value amounting to $1.0.

  • NewAmsterdam Pharma's Shares Outstanding (Weighted Average) changed N/A to $1.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $1.0, marking a year-over-year change of. This contributed to the annual value of $0.98 for FY2022, which is N/A changed from last year.
  • NewAmsterdam Pharma's Shares Outstanding (Weighted Average) amounted to $1.0 in Q2 2023.
  • Over the past 5 years, NewAmsterdam Pharma's Shares Outstanding (Weighted Average) peaked at $1.0 during Q2 2023, and registered a low of $0.98 during Q4 2022.